Works by Shimizu, Takuto


Results: 51
    1

    Impact of Initial Relative Dose Intensity on Tumor Response and Survival Outcomes in Enfortumab Vedotin Monotherapy for Previously Treated Advanced Urothelial Carcinoma: A Real-world Analysis From a Multicenter Study.

    Published in:
    Clinical Genitourinary Cancer, 2025, v. 23, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2025.102326
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Iemura, Yusuke;
    • Yoshikawa, Motokiyo;
    • Torimoto, Kazumasa;
    • Tomioka, Atsushi;
    • Sakamoto, Keichi;
    • Matsumura, Yoshiaki;
    • Naoi, Makito;
    • Ichii, Daiki;
    • Inoue, Kuniaki;
    • Narita, Kosuke;
    • Oyama, Nobuo;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi
    Publication type:
    Article
    2
    3

    Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 329, doi. 10.1093/jjco/hyad170
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Ohmori, Chihiro;
    • Takamatsu, Norimi;
    • Itami, Yoshitaka;
    • Tachibana, Akira;
    • Matsumoto, Yoshihiro;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Okajima, Eijiro;
    • Masaomi, Kuwata;
    • Sakamoto, Keichi;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    4

    Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette–Guerin.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 629, doi. 10.1093/jjco/hyad029
    By:
    • Miyake, Makito;
    • Hori, Shunta;
    • Fujii, Tomomi;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    5

    The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 4, p. 343, doi. 10.1093/jjco/hyac203
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Morizawa, Yosuke;
    • Hori, Shunta;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    6

    Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 253, doi. 10.1093/jjco/hyac186
    By:
    • Miyake, Makito;
    • Shimizu, Takuto;
    • Oda, Yuki;
    • Tachibana, Akira;
    • Ohmori, Chihiro;
    • Itami, Yoshitaka;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Yamamoto, Hiroaki;
    • Ohnishi, Kenta;
    • Nishimura, Nobutaka;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    7
    8
    9

    Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors.

    Published in:
    Cancers, 2024, v. 16, n. 4, p. 841, doi. 10.3390/cancers16040841
    By:
    • Shimizu, Takuto;
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Yoshida, Takanori;
    • Itami, Yoshitaka;
    • Tachibana, Akira;
    • Omori, Chihiro;
    • Oda, Yuki;
    • Kohashi, Mikiko;
    • Tomizawa, Mitsuru;
    • Onishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Dotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    10

    Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study.

    Published in:
    Cancers, 2022, v. 14, n. 7, p. 1735, doi. 10.3390/cancers14071735
    By:
    • Shimizu, Takuto;
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Inoue, Kuniaki;
    • Fujii, Koyo;
    • Iemura, Yusuke;
    • Ichikawa, Kazuki;
    • Omori, Chihiro;
    • Tomizawa, Mitsuru;
    • Maesaka, Fumisato;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Sakamoto, Keiichi;
    • Kiba, Keisuke;
    • Tanaka, Masahiro;
    • Oyama, Nobuo;
    • Okajima, Eijiro;
    • Fujimoto, Ken;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    11

    Intravesical Bacillus Calmette–Guérin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies.

    Published in:
    Cancers, 2021, v. 13, n. 11, p. 2615, doi. 10.3390/cancers13112615
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Iida, Kota;
    • Fujii, Tomomi;
    • Nishikawa, Ryoma;
    • Teraoka, Shogo;
    • Takenaka, Atsushi;
    • Kikuchi, Hiroshi;
    • Abe, Takashige;
    • Shinohara, Nobuo;
    • Okajima, Eijiro;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Tsuchiya, Norihiko;
    • Owari, Takuya;
    • Murakami, Yasukiyo;
    • Taoka, Rikiya;
    • Kobayashi, Takashi;
    • Kojima, Takahiro;
    • Nishiyama, Naotaka
    Publication type:
    Article
    12
    13

    Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer.

    Published in:
    International Urology & Nephrology, 2024, v. 56, n. 3, p. 827, doi. 10.1007/s11255-023-03851-3
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Nishioka, Yuichi;
    • Fujii, Tomomi;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Imamura, Tomoaki;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    14
    15
    16
    17

    Long‐term follow‐up of congenital hydronephrosis in a single‐center study.

    Published in:
    International Journal of Urology, 2024, v. 31, n. 5, p. 507, doi. 10.1111/iju.15391
    By:
    • Morizawa, Yosuke;
    • Aoki, Katsuya;
    • Fukui, Shinji;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Onishi, Kenta;
    • Hori, Shunta;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Miyake, Makito;
    • Torimoto, Kazumasa;
    • Fujimoto, Ken;
    • Otani, Takeshi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    18
    19
    20

    Clinical significance of limited and extended pelvic lymph node dissection during robot‐assisted radical prostatectomy for patients with localized prostate cancer: A retrospective, propensity score matching analysis.

    Published in:
    International Journal of Urology, 2023, v. 30, n. 2, p. 168, doi. 10.1111/iju.15075
    By:
    • Hori, Shunta;
    • Nakai, Yasushi;
    • Tachibana, Akira;
    • Omori, Chihiro;
    • Nishimura, Nobutaka;
    • Inoue, Kuniaki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Miyake, Makito;
    • Torimoto, Kazumasa;
    • Yoneda, Tatsuo;
    • Fujimoto, Kiyohide;
    • Tanaka, Nobumichi
    Publication type:
    Article
    21
    22

    Trends in risk classification at diagnosis and choice of primary therapy for prostate cancer: An analysis of 10 839 patients from the Nara Urological Research and Treatment Group registry between 2004 and 2015.

    Published in:
    International Journal of Urology, 2021, v. 28, n. 11, p. 1164, doi. 10.1111/iju.14666
    By:
    • Nakai, Yasushi;
    • Tanaka, Nobumichi;
    • Fujii, Tomomi;
    • Miyake, Makito;
    • Anai, Satoshi;
    • Hori, Shunta;
    • Shimizu, Takuto;
    • Onishi, Mikiko;
    • Ichikawa, Kazuki;
    • Onishi, Kenta;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    23

    Clinical benefit of early treatment with bone‐modifying agents for preventing skeletal‐related events in patients with genitourinary cancer with bone metastasis: A multi‐institutional retrospective study.

    Published in:
    International Journal of Urology, 2019, v. 26, n. 6, p. 630, doi. 10.1111/iju.13939
    By:
    • Owari, Takuya;
    • Miyake, Makito;
    • Nakai, Yasushi;
    • Hori, Shunta;
    • Tomizawa, Mitsuru;
    • Ichikawa, Kazuki;
    • Shimizu, Takuto;
    • Iida, Kota;
    • Samma, Shoji;
    • Iemura, Yusuke;
    • Momose, Hitoshi;
    • Omori, Chihiro;
    • Otani, Takeshi;
    • Kuwada, Masaomi;
    • Hirao, Shuya;
    • Oyama, Nobuo;
    • Nakagawa, Yoshinori;
    • Hayashi, Yoshiki;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    24

    Ganglioside GM3 deficiency enhances mast cell sensitivity.

    Published in:
    FEBS Journal, 2023, v. 290, n. 17, p. 4268, doi. 10.1111/febs.16806
    By:
    • Komuro, Mariko;
    • Mizugaki, Hinano;
    • Nagane, Masaki;
    • Morimoto, Misako;
    • Fukuyama, Tomoki;
    • Ogihara, Kikumi;
    • Naya, Yuko;
    • Yokomori, Emi;
    • Kaneshima, Kimika;
    • Kawakami, Yasushi;
    • Kamiie, Junichi;
    • Shibata, Yuki;
    • Suzuki, Mira;
    • Shimizu, Takuto;
    • Kawashima, Nagako;
    • Okamoto, Mariko;
    • Ikeda, Teruo;
    • Yamashita, Tadashi
    Publication type:
    Article
    25

    Difference of oncological efficacy between two immune checkpoint inhibitors following first-line platinum-based chemotherapy in patients with unresectable, metastatic, advanced urothelial carcinoma: a multicenter real-world Japanese cohort.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 9, p. 1311, doi. 10.1007/s10147-024-02573-5
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Iida, Kota;
    • Inoue, Kuniaki;
    • Tachibana, Akira;
    • Yoshikawa, Takanosuke;
    • Sakamoto, Keichi;
    • Ohnishi, Mikiko;
    • Maesaka, Fumisato;
    • Takamatsu, Norimi;
    • Mieda, Kosuke;
    • Ohmori, Chihiro;
    • Matsubara, Toshihiko;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke
    Publication type:
    Article
    26

    First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 11, p. 1733, doi. 10.1007/s10147-022-02230-9
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Shimizu, Takuto;
    • Matsubara, Toshihiko;
    • Miyamoto, Tatsuki;
    • Sakamoto, Keichi;
    • Yamada, Atsushi;
    • Matsumoto, Yoshihiro;
    • Yoshikawa, Motokiyo;
    • Ichikawa, Kazuki;
    • Omori, Chihiro;
    • Maesaka, Fumisato;
    • Oda, Yuki;
    • Kiba, Keisuke;
    • Tomioka, Atsushi;
    • Hosokawa, Yukinari;
    • Tanaka, Masahiro;
    • Otani, Takeshi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    27

    Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 7, p. 6145, doi. 10.1007/s00520-022-07043-0
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Ohnishi, Sayuri;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    28

    Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale.

    Published in:
    Journal of Chemotherapy (Taylor & Francis Ltd), 2025, v. 37, n. 2, p. 146, doi. 10.1080/1120009X.2024.2340885
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    29

    Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data

    Published in:
    Cancer Management & Research, 2022, v. 14, p. 623, doi. 10.2147/CMAR.S348899
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Shimizu, Takuto;
    • Ohnishi, Mikiko;
    • Kuwada, Masaomi;
    • Itami, Yoshitaka;
    • Inoue, Takeshi;
    • Ohnishi, Kenta;
    • Matsumoto, Yoshihiro;
    • Yoshida, Takanori;
    • Tatsumi, Yoshihiro;
    • Shinohara, Masatake;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Aoki, Katsuya;
    • Fujii, Tomomi
    Publication type:
    Article
    30

    Initial experience of complete laparoscopic radical nephroureterectomy combined with transvesical laparoscopic excision of distal ureter in patients with upper urinary tract cancer.

    Published in:
    World Journal of Surgical Oncology, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12957-020-01872-1
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Aoki, Katsuya;
    • Ohmori, Chihiro;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    31
    32
    33

    Supplementary granulocyte macrophage colony‐stimulating factor to chemotherapy and programmed death‐ligand 1 blockade decreases local recurrence after surgery in bladder cancer.

    Published in:
    Cancer Science, 2019, v. 110, n. 10, p. 3315, doi. 10.1111/cas.14158
    By:
    • Miyake, Makito;
    • Hori, Shunta;
    • Ohnishi, Sayuri;
    • Toritsuka, Michihiro;
    • Fujii, Tomomi;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Itami, Yoshitaka;
    • Nakai, Yasushi;
    • Anai, Satoshi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    34
    35
    36

    Successful salvage of allograft dysfunction triggered by transplant renal vein thrombosis immediately after kidney transplantation: a case report.

    Published in:
    International Journal of Nephrology & Renovascular Disease, 2018, v. 11, p. 321, doi. 10.2147/IJNRD.S185520
    By:
    • Hori, Shunta;
    • Miyamoto, Tatsuki;
    • Sakamoto, Keiichi;
    • Shimizu, Takuto;
    • Ichikawa, Kazuki;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Miyake, Makito;
    • Yoneda, Tatsuo;
    • Tanaka, Nobumichi;
    • Yoshida, Katsunori;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    37

    Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma.

    Published in:
    Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. 196.e1, doi. 10.1016/j.clgc.2021.11.006
    By:
    • Makito Miyake;
    • Takuto Shimizu;
    • Nobutaka Nishimura;
    • Keisuke Kiba;
    • Fumisato Maesaka;
    • Yuki Oda;
    • Akira Tachibana;
    • Mitsuru Tomizawa;
    • Chihiro Ohmori;
    • Yoshiaki Matsumura;
    • Kazuki Ichikawa;
    • Shinichiro Mizobuchi;
    • Takanosuke Yoshikawa;
    • Shunta Hori;
    • Yosuke Morizawa;
    • Daisuke Gotoh;
    • Yasushi Nakai;
    • Satoshi Anai;
    • Kazumasa Torimoto;
    • Katsuya Aoki
    Publication type:
    Article
    38
    39
    40
    41
    42

    Immunosuppressant-Induced Alteration of Gut Microbiota Causes Loss of Skeletal Muscle Mass: Evidence from Animal Experiments Using Mice and Observational Study on Humans.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 5, p. 1628, doi. 10.3390/jcm14051628
    By:
    • Tomizawa, Mitsuru;
    • Hori, Shunta;
    • Yoneda, Tatsuo;
    • Maesaka, Fumisato;
    • Onishi, Sayuri;
    • Shimizu, Takuto;
    • Onishi, Kenta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Miyake, Makito;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    43

    Comparison of Post‐Radical Cystectomy Renal Function and Ileal Conduit‐Related Complications Between Extracorporeal and Robot‐Assisted Intracorporeal Urinary Diversion: A Single‐Center Experience.

    Published in:
    Asian Journal of Endoscopic Surgery, 2025, v. 18, n. 1, p. 1, doi. 10.1111/ases.70033
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Iida, Kota;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Inoue, Takeshi;
    • Anai, Satoshi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    44
    45

    Photodynamic Therapeutic Effect during 5‐Aminolevulinic Acid‐Mediated Photodynamic Diagnosis‐Assisted Transurethral Resection of Bladder Tumors.

    Published in:
    Advances in Urology, 2024, v. 2024, p. 1, doi. 10.1155/2024/7548001
    By:
    • Nishimura, Nobutaka;
    • Miyake, Makito;
    • Onishi, Sayuri;
    • Fujii, Tomomi;
    • Miyamoto, Tatsuki;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Morizawa, Yosuke;
    • Hori, Shunta;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide;
    • Zhou, Xuelin
    Publication type:
    Article
    46
    47

    A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial

    Published in:
    Methods & Protocols, 2024, v. 7, n. 4, p. 58, doi. 10.3390/mps7040058
    By:
    • Miyake, Makito;
    • Anai, Satoshi;
    • Iemura, Yusuke;
    • Ichikawa, Kazuki;
    • Miyamoto, Tatsuki;
    • Tomioka, Atsushi;
    • Kuwada, Masaomi;
    • Itami, Yoshitaka;
    • Hosokawa, Yukinari;
    • Matsumura, Yoshiaki;
    • Okajima, Eijiro;
    • Torimoto, Kazumasa;
    • Nishimura, Nobutaka;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Fujimoto, Kiyohide
    Publication type:
    Article
    48
    49
    50

    Longitudinal assessment of health-related quality of life in Japanese patients with advanced urothelial carcinoma receiving immune check point inhibitors.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72755-8
    By:
    • Miyake, Makito;
    • Nishimura, Nobutaka;
    • Oda, Yuki;
    • Miyamoto, Tatsuki;
    • Iida, Kota;
    • Tomizawa, Mitsuru;
    • Shimizu, Takuto;
    • Owari, Takuya;
    • Ohnishi, Kenta;
    • Hori, Shunta;
    • Morizawa, Yosuke;
    • Gotoh, Daisuke;
    • Nakai, Yasushi;
    • Torimoto, Kazumasa;
    • Fujii, Tomomi;
    • Tanaka, Nobumichi;
    • Fujimoto, Kiyohide
    Publication type:
    Article